In just a couple weeks. That's not just the ABBV deal. I think we're seeing a bit of a let down on the breast cancer front, some of the ABBV deal, and some selling to lock in gains. In addition, I'm sure there are some who are not happy to see MDVN invest in another drug as they would rather see the company bought out vs. try to become a drug powerhouse. My fear is that there is some negative news leaking out about the trials for first line treatment. I certainly hope that is not the case but we small fish are the last to hear the news. ALWAYS.
I'm hopeful the stock will recover when big money comes back after the holiday break. Time will tell. Either way, it's certainly not nice to see such a big drop in such a short time. It doesn't make for happy investors!
Do you all think that next week will make any difference in the share price one way or another based on the results of the breast cancer trials? Are we far enough along with those trials for it to move the stock?